US firm expands Hepatitis C generic licensing agreement to Malaysia


PETALING JAYA: More Hepatitis C patients will soon be able to afford treatment, thanks to the decision by a US pharmaceutical company to expand its generic licensing agreement to Malaysia.

Gilead Science, an American research-based biopharmaceutical company, announced its decision on Aug 24 to expand its HIV and Hepatitis C generic licensing agreement to Malaysia, Thailand, Ukraine and Belarus.

Hailing the development, local think-tank Galen Centre for Health and Social Policy said it would be a “game changer” in the fight against Hepatitis C in the country.

Its chief executive officer Azrul Mohd Khalib said more than 400,000 Malaysians between 15 and 60 years old are currently estimated to be living with Hepatitis C.

“With Hepatitis C treatment currently costing as much as US$30,000 (RM128,115) per person, this granting of a Sofosbuvir voluntary licence by Gilead Sciences will mean that it will be possible for lower-cost generic versions of this life-saving drug to be made available in Malaysia.

“It will allow for the drug to be used in combination with others.

“Most importantly, it will be possible for thousands of lives to be treated and cured of this disease,” he said.

Sofosbuvir is the innovator drug owned by Gilead Sciences.

Azrul also hoped that with access to the drug, the Health Ministry would be in a better position to work together with non-governmental organisations, patient groups and the pharmaceutical sector towards achieving its goal of ensuring that those in need of Hepatitis C treatment “can get it and afford to do so”.

Previously, The Star reported that it may cost up to RM300,000 for patients to have a full course of treatment.

This was because Malaysia was not given special pricing for the drugs by pharmaceutical companies as it is considered as a middle-income nation.

In July, the Health Ministry acknowledged that the treatment for Hepatitis C is very expensive and it was collaborating with other partners to find an affordable cure.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In Nation

Covid-19: 19 new clusters identified, 10 linked to workplaces
New Mukah Airport to start operating on Thursday (June 17), says Dr Wee
Covid-19: Cases decrease but ICU admissions remain high, says Health DG
Covid-19: 73 more deaths bring total number of casualties to 4,142
Covid-19: Sabah to treat all deaths outside hospitals as Covid-19 related until proven otherwise
Keningau cops: Mum did not sell children, no human trafficking as claimed
Virologist suggests cutting time between AstraZeneca doses to eight weeks
Give kids born overseas to Malaysian women equal rights to secure Malaysian citizenship, says MCA
No need to extend Emergency beyond Aug 1, say Malay Rulers
Several localities in KL, Sabah, Sarawak to be placed under EMCO starting June 18

Stories You'll Enjoy


Vouchers